Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,460 | 35,233 | 25,987 | 64,937 | 46,044 |
| Marketable Securities | 3,978 | 11,152 | 25,884 | 37,617 | 107,744 |
| Receivables | 2,422 | 35,834 | 34,108 | 163 | 507 |
| Inventories | 18,749 | 16,084 | 9,706 | 6,591 | 7,861 |
| Other current assets | 5,801 | 8,131 | 6,184 | 0 | 0 |
| TOTAL | $62,410 | $106,434 | $101,869 | $118,696 | $172,320 |
| Non-Current Assets | |||||
| PPE Net | 2,317 | 2,989 | 3,856 | 4,628 | 5,349 |
| Other Non-Current Assets | 52,557 | 55,849 | 59,779 | 65,464 | 68,770 |
| TOTAL | $54,874 | $58,838 | $63,635 | $70,092 | $74,119 |
| Total Assets | $117,284 | $165,272 | $165,504 | $188,788 | $246,439 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,253 | 2,854 | 3,684 | 6,511 | 4,138 |
| Accrued Expenses | 7,269 | 5,707 | 11,519 | 14,430 | 12,556 |
| Other current liabilities | 26,149 | 33,047 | 31,826 | 22,569 | 25,172 |
| TOTAL | $148,267 | $180,690 | $142,226 | $79,089 | $74,552 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 107,582 | 123,154 | 77,833 | 11,611 | 11,949 |
| Other Non-Current Liabilities | 79,318 | 82,171 | 84,947 | 86,608 | 88,868 |
| TOTAL | $79,885 | $82,890 | $122,509 | $160,537 | $164,433 |
| Total Liabilities | $228,152 | $263,580 | $264,735 | $239,626 | $238,985 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,915 | 4,817 | 4,774 | 4,077 | 4,044 |
| Common Shares | N/A | 12 | N/A | 10 | 10 |
| Retained earnings | -2,019,951 | -2,000,902 | -1,969,150 | -1,908,700 | -1,838,903 |
| Other shareholders' equity | -14 | -55 | -204 | -571 | -933 |
| TOTAL | $-110,868 | $-98,308 | $-99,231 | $-50,838 | $7,454 |
| Total Liabilities And Equity | $117,284 | $165,272 | $165,504 | $188,788 | $246,439 |